Search results for "73"

showing 10 items of 739 documents

Note sous Civ. 1ère, 28 novembre 2006

2007

International audience

loi marocaine[SHS.DROIT] Humanities and Social Sciences/Lawconvention franco-marocaine du 10 août 1981divorce[ SHS.DROIT ] Humanities and Social Sciences/Lawallocation pécuniaire après divorce insuffisanteDroit international privécontrariété à l'ordre public international françaisordre public internationaleffets entre époux[SHS.DROIT]Humanities and Social Sciences/Lawapplication du droit françaisconvention de La Haye du 2 octobre 1973ComputingMilieux_MISCELLANEOUSloi applicableprestation compensatoire
researchProduct

Differential influence of vemurafenib and dabrafenib on patient lymphocytes despite similar clinical efficacy in melanoma

2014

Background: Since the majority of melanomas eventually become resistant and progress, combining selective BRAF inhibitors (BRAFi) with immunotherapies has been proposed to achieve more durable treatment responses. Here, we explored the impact of selective BRAFi on the hosts’ immune system. Patients and methods: Clinical data, whole blood counts (WBC) and serum lactate dehydrogenase (LDH) of 277 vemurafenib- and 65 dabrafenib-treated melanoma patients were evaluated. The frequency and phenotype of lymphocyte subpopulations were determined by flow cytometry while T cell cytokine secretion was measured by multiplex assays. Results: Progression-free survival (PFS) as well as overall survival (O…

lymphocytesmedicine.medical_treatmentT cellLymphocyte2720 HematologyMedizinT cells610 Medicine & healthPharmacology142-005 142-005melanomamedicineInterleukin 9dabrafenibVemurafenibtreatmentbusiness.industryMelanomaDabrafenibOriginal ArticlesHematologyImmunotherapymedicine.diseasemedicine.anatomical_structureOncology2730 OncologyvemurafenibCytokine secretionbusinessmedicine.drug
researchProduct

Mutant HRAS as novel target for MEK and mTOR inhibitors.

2015

HRAS is a frequently mutated oncogene in cancer. However, mutant HRAS as drug target has not been investigated so far. Here, we show that mutant HRAS hyperactivates the RAS and the mTOR pathway in various cancer cell lines including lung, bladder and esophageal cancer. HRAS mutation sensitized toward growth inhibition by the MEK inhibitors AZD6244, MEK162 and PD0325901. Further, we found that MEK inhibitors induce apoptosis in mutant HRAS cell lines but not in cell lines lacking RAS mutations. In addition, knockdown of HRAS by siRNA blocked cell growth in mutant HRAS cell lines. Inhibition of the PI3K pathway alone or in combination with MEK inhibitors did not alter signaling nor had an imp…

mTOR inhibitorMutantBlotting Western610 Medicine & healthApoptosisMice SCIDCell LineProto-Oncogene Proteins p21(ras)chemistry.chemical_compoundCell Line TumorNeoplasmsMedicineAnimalsHumansHRASHRAS mutationsProtein Kinase InhibitorsPI3K/AKT/mTOR pathwayCell ProliferationGeneticsMitogen-Activated Protein Kinase KinasesMEK inhibitorOncogeneCell growthbusiness.industryMEK inhibitorTOR Serine-Threonine KinasesDiphenylamineXenograft Model Antitumor AssaysTumor Burdenlung cancer10219 Clinic for Gastroenterology and HepatologyCell Transformation NeoplasticOncologychemistry10032 Clinic for Oncology and HematologyBenzamidesMutationCancer researchbladder cancer2730 OncologyBenzimidazolesRNA InterferenceSignal transductionGrowth inhibitionbusinessSignal TransductionResearch PaperOncotarget
researchProduct

Automatic Processing of Changes in Facial Emotions in Dysphoria: A Magnetoencephalography Study

2018

It is not known to what extent the automatic encoding and change detection of peripherally presented facial emotion is altered in dysphoria. The negative bias in automatic face processing in particular has rarely been studied. We used magnetoencephalography (MEG) to record automatic brain responses to happy and sad faces in dysphoric (Beck’s Depression Inventory ≥ 13) and control participants. Stimuli were presented in a passive oddball condition, which allowed potential negative bias in dysphoria at different stages of face processing (M100, M170, and M300) and alterations of change detection (visual mismatch negativity, vMMN) to be investigated. The magnetic counterpart of the vMMN was el…

magnetoencephalographyMismatch negativityAutomatic processinghavaitseminenfacial expressionsAudiology170 Ethics2738 Psychiatry and Mental HealthBehavioral Neuroscience0302 clinical medicine2802 Behavioral Neurosciencechange detectionta515dysphoriaOriginal ResearchMEGmedicine.diagnostic_test05 social sciencesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyNeurologymedicine.symptomPsychology2803 Biological PsychiatryChange detectionmasennusmedicine.medical_specialtydepression (mental disorders)610 Medicine & healthOccipital regionemotionsDysphoriata3112behavioral disciplines and activities050105 experimental psychologylcsh:RC321-5713206 Neuropsychology and Physiological Psychology03 medical and health sciencesperception (activity)Group differencestunteetmedicineemotional faces10237 Institute of Biomedical Engineering0501 psychology and cognitive sciencesilmeetlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryMagnetoencephalographyNegative bias2808 Neurologyautomatic030217 neurology & neurosurgeryNeuroscienceFrontiers in Human Neuroscience
researchProduct

Dynamics in stochastic evolutionary models

2014

First published: 01 February 2016 We characterize transitions between stochastically stable states and relative ergodic probabilities in the theory of the evolution of conventions. We give an application to the fall of hegemonies in the evolutionary theory of institutions and conflict, and illustrate the theory with the fall of the Qing dynasty and the rise of communism in China. We are especially indebted to Juan Block for his many comments and suggestions. We would also like to thank Drew Fudenberg, Kevin Hasker, Matt Jackson, Peyton Young, and five anonymous referees. We are grateful to NSF Grant SES-08-51315 and to the MIUR PRIN 20103S5RN3 for financial support.

markov chainsEvolutionMarkov chainjel:C73conventionsEvolution conventionsmarkov chainsstate powerEconomics Econometrics and Finance (all)2001 Economics Econometrics and Finance (miscellaneous)C73state powerPracticesconventionddc:330Equilibrium SelectionLawPragmatismconventions; Evolution; Markov chains; state power; Economics Econometrics and Finance (all)2001 Economics Econometrics and Finance (miscellaneous)Theoretical Economics
researchProduct

Examining early adolescents' motivation for physical education : associations with actual and perceived motor competence

2020

Background: The dynamic nature of physical education (PE) requires careful consideration of lesson planning and delivery in order to promote health and wellbeing and to achieve various learning goals. One such goal is promoting personal and social development to support students to value and lead a healthy and active lifestyle, especially during transition into adolescence. In order to design learning environments that support students' engagement in PE, it is important to understand how outcomes such as motor competence (MC) influence motivation for PE. There are two approaches to understand MC, actual and perceived MC, and both have implications for healthy lifestyles in childhood and ado…

media_common.quotation_subjectLCPhysical Therapy Sports Therapy and RehabilitationRA773EducationPhysical educationDevelopmental psychologyPerceptionEarly adolescentsOrthopedics and Sports MedicinePsychologyCompetence (human resources)Motor skillmedia_common
researchProduct

Atherogenic dyslipidemia and oxidative stress: a new look

2009

Although results from in vitro studies and clinical trials demonstrate strong associations between oxidative stress and cardiovascular risk, to date still no convincing data are available to suggest that treatment with antioxidants might reduce vascular events. Oxidative modifications of low-density lipoproteins (LDL) represent an early stage of atherosclerosis, and small, dense LDL are more susceptible to oxidation than larger, more buoyant particles. Oxidized LDL are independent predictors of subclinical and clinical atherosclerosis. Recent studies suggested that novel therapeutic strategies may take into account the removal of such particles from circulation. Future research is required …

medicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthOxidative phosphorylation030204 cardiovascular system & hematology2704 Biochemistry (medical)medicine.disease_causeAtherogenic dyslipidemia oxidative stressCoronary artery disease03 medical and health sciences2737 Physiology (medical)0302 clinical medicinePhysiology (medical)Internal medicineHumansMedicineDyslipidemias030304 developmental biologySubclinical infectionchemistry.chemical_classification0303 health sciencesReactive oxygen speciesAtherogenic dyslipidemiabusiness.industryVascular diseaseBiochemistry (medical)Public Health Environmental and Occupational HealthAtherogenic dyslipidemia2739 Public Health Environmental and Occupational HealthGeneral MedicineAtherosclerosismedicine.disease3. Good healthLipoproteins LDLOxidative StressEndocrinologychemistrybusinessOxidized ldlOxidative stressTranslational Research
researchProduct

The differential effects of thiazolidindiones on atherogenic dyslipidemia in type 2 diabetes: what is the clinical significance?

2008

Diabetic dyslipidemia is typically characterized by an increase in plasma triglycerides, a decrease in high-density lipoprotein cholesterol and a concomitant increase in atherogenic small dense low-density lipoproteins. Thiazolidindiones are able to lower the levels of fasting glucose and glycated hemoglobin significantly by improving insulin sensitivity, as well as improving some aspects of diabetic dyslipidemia: total cholesterol, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol tend to increase while triglycerides are generally decreased.This paper reviewed the effects of pioglitazone and rosiglitazone on atherogenic diabetic dyslipidemia, in particular on sma…

medicine.medical_specialty10265 Clinic for Endocrinology and Diabetology610 Medicine & healthType 2 diabetesRosiglitazonechemistry.chemical_compoundDiabetes mellitusInternal medicinemedicine2736 Pharmacology (medical)HumansHypoglycemic AgentsPharmacology (medical)Clinical significancecardiovascular risk dense low-density lipoprotein diabetes low-density lipoprotein size pioglitazone rosiglitazone smallTriglyceridesDyslipidemiasPharmacologyAtherogenic dyslipidemiaPioglitazonebusiness.industryThiazolidindionesAtherogenic dyslipidemiaGeneral Medicinemedicine.diseaseLipoproteins LDLEndocrinology3004 PharmacologychemistryDiabetes Mellitus Type 2lipids (amino acids peptides and proteins)ThiazolidinedionesGlycated hemoglobinbusinessRosiglitazoneLipoproteins HDLPioglitazoneBiomarkersmedicine.drugLipoprotein
researchProduct

Increase in physical activity and cardiometabolic risk profile change during lifestyle intervention in primary healthcare: 1-year follow-up study amo…

2011

Objectives To investigate the association between increase in physical activity and changes in cardiometabolic risk factors during a lifestyle intervention programme in routine clinical settings. Design Prospective follow-up. Setting 400 primary healthcare centres and occupational healthcare outpatient clinics in Finland. Participants Individuals at high risk for type 2 diabetes identified in the implementation project of the national diabetes prevention programme (FIN-D2D) and participating in baseline and 1-year follow-up visits. Final study group comprised the 1871 non-diabetic participants who responded at follow-up visit to a question on stability versus increase of physical activity. …

medicine.medical_specialty1688Psychological intervention030209 endocrinology & metabolismType 2 diabetes03 medical and health sciences0302 clinical medicineDiabetes mellitusHealth caremedicine1724Outpatient clinic15061704030212 general & internal medicine1696business.industryResearchPublic healthHealth services researchGeneral Medicinemedicine.disease3. Good healthDiabetes and EndocrinologyBlood pressurePhysical therapy1736businessBMJ Open
researchProduct

Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorect…

2013

Objectives To capture an accurate contemporary description of the practice of pulmonary metastasectomy for colorectal carcinoma in one national healthcare system. Design A national registry set up in Spain by Grupo Espanol de Cirugia Metastasis Pulmonares de Carcinoma Colo-Rectal (GECMP-CCR). Setting 32 Spanish thoracic units. Participants All patients with one or more histologically proven lung metastasis removed by surgery between March 2008 and February 2010. Interventions Pulmonary metastasectomy for one or more pulmonary nodules proven to be metastatic colorectal carcinoma. Primary and secondary outcome measures The age and sex of the patients having this surgery were recorded with the…

medicine.medical_specialtyCirurgia colorectalMediastinal lymphadenopathyColorectal cancerMetastasisMetastasisCarcinoembryonic antigenMetàstasiCàncer colorectalColorectal surgerymedicineCarcinoma1506Prospective cohort studyPathological16941695biologybusiness.industryResearchGeneral surgeryGeneral Medicinemedicine.diseaseColorectal cancerSurgeryOncologybiology.protein1737Metastasectomy1717business
researchProduct